Levetiracetam LEV CAS 102767-28-2 API faktori USP EP Standard High Purity
Pwovizyon pou manifakti ak pite segondè ak bon jan kalite ki estab
Non chimik: Levetiracetam
CAS: 102767-28-2
API USP / EP Creole, Pwodiksyon Komèsyal
Twazyèm jenerasyon dwòg antiepileptik
Non Chimik | Levetiracetam |
Sinonim | LEV;(S)-2-(2-Oxo-1-pirolidinil) butiramid;UCB-L059 |
Nimewo CAS | 102767-28-2 |
Nimewo CAT | RF-API61 |
Estati Stock | Nan Stock, Pwodiksyon Echèl Jiska Tòn |
Fòmil molekilè | C8H14N2O2 |
Pwa molekilè | 170.21 |
Pwen k ap fonn | 116.0-119.0℃ |
Mak | Ruifu Chimik |
Atik | Espesifikasyon |
Aparans | Poud kristal blan oswa prèske blan |
Idantifikasyon IR | Spectre ki te jwenn nan echantiyon an konsiste de sa ki te jwenn nan sibstans referans |
Aparans nan solisyon | Klè epi li pa gen plis koulè pase BY6 |
Enantiomeric Pite Enpurite D | ≤0.80% |
Dlo | ≤0.50% |
Sann sulfate | ≤0.10% |
Metal lou | ≤0.001% |
Sibstans ki gen rapò | |
Enpurte A | ≤0.30% |
Nenpòt enpurte ki pa espesifye | ≤0.05% |
Total enpurte ki pa espesifye | ≤0.10% |
Enpurte total | ≤0.40% |
Enpurte F | ≤0.10% |
Solvang rezidyèl | |
Benzèn | ≤2ppm |
Diklorometan | ≤600ppm |
Acetate etil | ≤5000ppm |
Asetòn | ≤5000ppm |
Esè | 98.0% ~ 102.0% |
Tès Creole | USP Standard;EP estanda |
Itilizasyon | API Twazyèm jenerasyon dwòg antiepileptik |
Pake: Boutèy, sak papye aliminyòm, tanbou katon, 25kg / tanbou, oswa selon kondisyon kliyan an.
Kondisyon Depo:Sere nan resipyan ki fèmen nan yon kote ki fre ak sèk;Pwoteje kont limyè, imidite ak ensèk nuizib.
![1](https://www.ruifuchemical.com/uploads/15.jpg)
![](https://www.ruifuchemical.com/uploads/23.jpg)
Levetiracetam (CAS: 102767-28-2), yon dérivés de pilacetam, se yon nouvo twazyèm-jenerasyon dwòg antiepileptik apwouve pa US FDA an 1999. Li te okòmansman itilize pou tretman an adjunctive nan kriz pasyèl nan granmoun.Nan 2005, Levetiracetam te apwouve nan tablèt oral ak solisyon pou tretman an adjuntive nan kriz pasyèl nan timoun ki gen laj 4 ane ak plis.Li se sitou itilize pou tretman aditif nan kriz pasyèl nan granmoun ak timoun ki gen plis pase 4 ane fin vye granmoun, epi li kapab tou itilize sèlman pou kriz pasyèl ak kriz sistemik nan granmoun.Li gen tou sèten efè guérison sou epilepsi myoklonik nan adolesan, epilepsi refractory, epilepsi absan nan timoun ak epilepsi ki pèsistan.
-
Levetiracetam LEV CAS 102767-28-2 API faktori U...
-
(S)-2-Aminobutyramide Hydrochloride CAS 7682-20...
-
(R)-2-Aminobutanamide Hydrochloride CAS 103765-...
-
Pregabalin CAS 148553-50-8 Pite > 99.0% (HPLC)...
-
Perindopril Erbumine CAS 107133-36-8 Pite> 99...
-
Olaparib AZD-2281 CAS 763113-22-0 Pite ≥99.0%...
-
Lapatinib Base CAS 231277-92-2 Pite ≥99.0% (H...
-
Irinotecan Hydrochloride Trihydrate CAS 136572-...
-
Irinotecan Free Base CAS 97682-44-5 Assay ≥99.0...
-
Ibrutinib CAS 936563-96-1 Pite > 99.5% (HPLC) API
-
Imatinib Mesylate CAS 220127-57-1 Essay 98.0% ~ 1...
-
Fingolimod Hydrochloride CAS 162359-56-0 Pite...
-
Gabapentin CAS 60142-96-3 Pite> 99.5% (HPLC) ...
-
Gemcitabine Hydrochloride CAS 122111-03-9 API U...
-
Glimepirid CAS 93479-97-1 Essay 98.0% ~ 102.0% A...
-
Enalapril Maleate CAS 76095-16-4 Essay 98.0 ~ 102...